GPi 688

Discontinued Product

3967 has been discontinued.

View all Phosphorylases products.
说明: Allosteric glycogen phosphorylase inhibitor
化学名: 2-Chloro-N-[1-[(2R)-2,3-dihydroxypropyl]-1,2,3,4-tetrahydro-2-oxo-3-quinolinyl]-6H-thieno[2,3-b]pyrrole-5-carboxamide
纯度: ≥99% (HPLC)
说明书
引用文献
评论

生物活性 for GPi 688

GPi 688 is an allosteric glycogen phosphorylase inhibitor; acts at the indole site of glycogen phosphorylase. Inhibits glucagon-mediated hyperglycemia in vivo in the rat.

许可信息

Sold with the permission of AstraZeneca UK Ltd.

技术数据 for GPi 688

分子量 419.88
公式 C19H18ClN3O4S
储存 Store at +4°C
纯度 ≥99% (HPLC)
CAS Number 918902-32-6
PubChem ID 10477191
InChI Key UICNBXVDHCBKCE-PUODRLBUSA-N
Smiles OC[C@H](O)CN(C1=CC=CC=C1CC2NC(C3=CC4=C(SC(Cl)=C4)N3)=O)C2=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

参考文献 for GPi 688

参考文献是支持产品生物活性的出版物。

Freeman et al (2006) Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme. Br.J.Pharmacol. 149 775 PMID: 17016495

Poucher et al (2007) An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia. Br.J.Pharmacol. 152 1239 PMID: 17934512

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Phosphorylase Inhibitors

关键词: GPi 688, GPi 688 supplier, GPi688, glycogen, phosphorylase, inhibitors, hyperglycaemia, hyperglycemia, inhibits, astrazeneca, Phosphorylases, 3967, Tocris Bioscience

篇 GPi 688 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 GPi 688 的引用文献。

GPi 688 的评论

目前没有该产品的评论。 Be the first to review GPi 688 and earn rewards!

Have you used GPi 688?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review